FDA panel unanimously votes to recommend GSK shingles vaccine
(Reuters) - A U.S. Food and Drug Administration advisory panel on Wednesday voted 11-0 that the safety and efficacy of GlaxoSmithKline's Shingrix shingles vaccine warrants approval for its use in adults aged 50 and over.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Food and Drug Administration (FDA) | Health | Shingles | Shingles (Herpes Zoster) Vaccine | Vaccines